{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:50:09Z","timestamp":1790787009574,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan, R.O.C.","doi-asserted-by":"crossref","award":["MOST 108-2314-B-075-041-MY3"],"award-info":[{"award-number":["MOST 108-2314-B-075-041-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V111C-022"],"award-info":[{"award-number":["V111C-022"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02372-w","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:05:36Z","timestamp":1657771536000},"page":"419-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association between bullous pemphigoid and atopic dermatitis: a population-based case\u2013control study in Taiwan"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2218-6083","authenticated-orcid":false,"given":"Po-Chien","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-1801","authenticated-orcid":false,"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Syuan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8393-3900","authenticated-orcid":false,"given":"Chen-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"2372_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108546","volume":"171","author":"CY Wu","year":"2021","unstructured":"Wu CY, Wu CY, Li CP et al (2021) Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a population-based cohort study. Diabetes Res Clin Pract 171:108546","journal-title":"Diabetes Res Clin Pract"},{"key":"2372_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.19022","volume":"184","author":"MSM Persson","year":"2021","unstructured":"Persson MSM, Harman KE, Vinogradova Y et al (2021) Incidence, prevalence and mortality of bullous pemphigoid in England 1998\u20132017: a population-based cohort study. Br J Dermatol 184:68\u201377","journal-title":"Br J Dermatol"},{"key":"2372_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2147\/CCID.S267573","volume":"15","author":"A Ruggiero","year":"2022","unstructured":"Ruggiero A, Megna M, Villani A et al (2022) Strategies to improve outcomes of bullous pemphigoid: a comprehensive review of clinical presentations, diagnosis, and patients\u2019 assessment. Clin Cosmet Investig Dermatol 15:661\u2013673","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2372_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","volume":"49","author":"N Ishiura","year":"2008","unstructured":"Ishiura N, Fujimoto M, Watanabe R et al (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49:153\u2013161","journal-title":"J Dermatol Sci"},{"key":"2372_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","volume":"78","author":"R Moriuchi","year":"2015","unstructured":"Moriuchi R, Nishie W, Ujiie H et al (2015) In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases. J Dermatol Sci 78:21\u201325","journal-title":"J Dermatol Sci"},{"key":"2372_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","volume":"165","author":"S Yayli","year":"2011","unstructured":"Yayli S, Pelivani N, Beltraminelli H et al (2011) Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Br J Dermatol 165:1133\u20131137","journal-title":"Br J Dermatol"},{"key":"2372_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","volume":"71","author":"KK Yu","year":"2014","unstructured":"Yu KK, Crew AB, Messingham KA et al (2014) Omalizumab therapy for bullous pemphigoid. J Am Acad Dermatol 71:468\u2013474","journal-title":"J Am Acad Dermatol"},{"key":"2372_CR8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/archdermatol.2012.1604","volume":"148","author":"VA London","year":"2012","unstructured":"London VA, Kim GH, Fairley JA et al (2012) Successful treatment of bullous pemphigoid with omalizumab. Arch Dermatol 148:1241\u20131243","journal-title":"Arch Dermatol"},{"key":"2372_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","volume":"166","author":"C Dufour","year":"2012","unstructured":"Dufour C, Souillet AL, Chaneliere C et al (2012) Successful management of severe infant bullous pemphigoid with omalizumab. Br J Dermatol 166:1140\u20131142","journal-title":"Br J Dermatol"},{"key":"2372_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40257-015-0171-3","volume":"17","author":"C Blome","year":"2016","unstructured":"Blome C, Radtke MA, Eissing L et al (2016) Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol 17:163\u2013169","journal-title":"Am J Clin Dermatol"},{"key":"2372_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jdin.2020.05.002","volume":"1","author":"YT Cho","year":"2020","unstructured":"Cho YT, Hsieh WT, Chan TC et al (2020) Prevalence of baseline comorbidities in patients with atopic dermatitis: a population-based cohort study in Taiwan. JAAD International 1:50\u201358","journal-title":"JAAD International"},{"issue":"500\u2013508","key":"2372_CR12","volume":"138","author":"M Feld","year":"2016","unstructured":"Feld M, Garcia R, Buddenkotte J et al (2016) The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol 138(500\u2013508):e524","journal-title":"J Allergy Clin Immunol"},{"key":"2372_CR13","doi-asserted-by":"crossref","unstructured":"Seidman JS, Eichenfield DZ, Orme CM (2019) Dupilumab for bullous pemphigoid with intractable pruritus. Dermatol Online J 25","DOI":"10.5070\/D32511046147"},{"key":"2372_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","volume":"43","author":"H Saeki","year":"2006","unstructured":"Saeki H, Tamaki K (2006) Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases. J Dermatol Sci 43:75\u201384","journal-title":"J Dermatol Sci"},{"key":"2372_CR15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/1346-8138.13330","volume":"43","author":"K Kamiya","year":"2016","unstructured":"Kamiya K, Aoyama Y, Nishio E et al (2016) Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis. J Dermatol 43:1102\u20131103","journal-title":"J Dermatol"},{"key":"2372_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.0022-202X.2005.23700.x","volume":"124","author":"S Kagami","year":"2005","unstructured":"Kagami S, Kakinuma T, Saeki H et al (2005) Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 124:1088\u20131090","journal-title":"J Invest Dermatol"},{"key":"2372_CR17","doi-asserted-by":"crossref","unstructured":"Kridin K, Ludwig RJ, Tzur Bitan D et al (2021) A history of asthma increases the risk of bullous pemphigoid: insights from a large population-based study. Dermatology 1\u20138","DOI":"10.1159\/000512917"},{"key":"2372_CR18","doi-asserted-by":"crossref","unstructured":"Kridin K, Hammers CM, Ludwig RJ, et al (2021) The association of bullous pemphigoid with atopic dermatitis and allergic rhinitis-a population-based study. Dermatitis","DOI":"10.1097\/DER.0000000000000792"},{"key":"2372_CR19","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2018062","volume":"40","author":"LY Lin","year":"2018","unstructured":"Lin LY, Warren-Gash C, Smeeth L et al (2018) Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health 40:e2018062","journal-title":"Epidemiol Health"},{"key":"2372_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","volume":"30","author":"G Di Zenzo","year":"2012","unstructured":"Di Zenzo G, Della Torre R, Zambruno G et al (2012) Bullous pemphigoid: from the clinic to the bench. Clin Dermatol 30:3\u201316","journal-title":"Clin Dermatol"},{"key":"2372_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.autrev.2015.01.006","volume":"14","author":"E Cozzani","year":"2015","unstructured":"Cozzani E, Gasparini G, Burlando M et al (2015) Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects. Autoimmun Rev 14:438\u2013445","journal-title":"Autoimmun Rev"},{"key":"2372_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1684\/ejd.2018.3366","volume":"28","author":"E Cozzani","year":"2018","unstructured":"Cozzani E, Gasparini G, Di Zenzo G et al (2018) Immunoglobulin E and bullous pemphigoid. Eur J Dermatol 28:440\u2013448","journal-title":"Eur J Dermatol"},{"key":"2372_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s001050051001","volume":"50","author":"W Kippes","year":"1999","unstructured":"Kippes W, Schmidt E, Roth A et al (1999) Immunopathologic changes in 115 patients with bullous pemphigoid. Hautarzt 50:866\u2013872","journal-title":"Hautarzt"},{"key":"2372_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2133.1992.tb11833.x","volume":"126","author":"A Parodi","year":"1992","unstructured":"Parodi A, Rebora A (1992) Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid. Br J Dermatol 126:526\u2013527","journal-title":"Br J Dermatol"},{"key":"2372_CR25","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1046\/j.0022-202x.2001.01505.x","volume":"117","author":"Y Teraki","year":"2001","unstructured":"Teraki Y, Hotta T, Shiohara T (2001) Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J Invest Dermatol 117:1097\u20131102","journal-title":"J Invest Dermatol"},{"key":"2372_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdermsci.2004.03.009","volume":"35","author":"M Inaoki","year":"2004","unstructured":"Inaoki M, Sato S, Takehara K (2004) Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE. J Dermatol Sci 35:53\u201359","journal-title":"J Dermatol Sci"},{"key":"2372_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0923-1811(94)90089-2","volume":"7","author":"F Furukawa","year":"1994","unstructured":"Furukawa F, Kumagai S, Sakamoto Y et al (1994) Elevated serum levels of IgE-binding factor\/soluble CD23 in bullous pemphigoid. J Dermatol Sci 7:150\u2013154","journal-title":"J Dermatol Sci"},{"key":"2372_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-2133.2003.05066.x","volume":"148","author":"T Kakinuma","year":"2003","unstructured":"Kakinuma T, Wakugawa M, Nakamura K et al (2003) High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 148:203\u2013210","journal-title":"Br J Dermatol"},{"key":"2372_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.clim.2006.03.014","volume":"120","author":"S Gounni Abdelilah","year":"2006","unstructured":"Gounni Abdelilah S, Wellemans V, Agouli M et al (2006) Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines. Clin Immunol 120:220\u2013231","journal-title":"Clin Immunol"},{"key":"2372_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332","journal-title":"Lancet"},{"key":"2372_CR31","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamadermatol.2018.2526","volume":"154","author":"A Kaye","year":"2018","unstructured":"Kaye A, Gordon SC, Deverapalli SC et al (2018) Dupilumab for the treatment of recalcitrant bullous pemphigoid. JAMA Dermatol 154:1225\u20131226","journal-title":"JAMA Dermatol"},{"key":"2372_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/STROKEAHA.110.596361","volume":"42","author":"YW Yang","year":"2011","unstructured":"Yang YW, Chen YH, Xirasagar S et al (2011) Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 42:319\u2013323","journal-title":"Stroke"},{"key":"2372_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ajd.12899","volume":"60","author":"K Phan","year":"2019","unstructured":"Phan K, Goyal S, Murrell DF (2019) Association between bullous pemphigoid and psoriasis: systematic review and meta-analysis of case\u2013control studies. Australas J Dermatol 60:23\u201328","journal-title":"Australas J Dermatol"},{"key":"2372_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jaad.2017.02.057","volume":"77","author":"K Kridin","year":"2017","unstructured":"Kridin K, Bergman R (2017) Association between bullous pemphigoid and psoriasis: a case\u2013control study. J Am Acad Dermatol 77:370\u2013372","journal-title":"J Am Acad Dermatol"},{"key":"2372_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/1346-8138.14902","volume":"46","author":"YH Ho","year":"2019","unstructured":"Ho YH, Hu HY, Chang YT et al (2019) Psoriasis is associated with increased risk of bullous pemphigoid: a nationwide population-based cohort study in Taiwan. J Dermatol 46:604\u2013609","journal-title":"J Dermatol"},{"key":"2372_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamadermatol.2014.5263","volume":"151","author":"SC Cai","year":"2015","unstructured":"Cai SC, Allen JC, Lim YL et al (2015) Association of Bullous Pemphigoid and Malignant Neoplasms. JAMA Dermatol 151:665\u2013667","journal-title":"JAMA Dermatol"},{"key":"2372_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123:144\u2013151","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2372_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40257-018-0383-4","volume":"19","author":"A Paller","year":"2018","unstructured":"Paller A, Jaworski JC, Simpson EL et al (2018) Major comorbidities of atopic dermatitis: beyond allergic disorders. Am J Clin Dermatol 19:821\u2013838","journal-title":"Am J Clin Dermatol"},{"key":"2372_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","volume":"48","author":"E Guttman-Yassky","year":"2017","unstructured":"Guttman-Yassky E, Krueger JG (2017) Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol 48:68\u201373","journal-title":"Curr Opin Immunol"},{"key":"2372_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.29","volume":"1","author":"A Cunliffe","year":"2021","unstructured":"Cunliffe A, Gran S, Ali U et al (2021) Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis. Skin Health Dis 1:e29","journal-title":"Skin Health Dis"},{"issue":"1335\u20131343","key":"2372_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.06.044","volume":"130","author":"DF Choy","year":"2012","unstructured":"Choy DF, Hsu DK, Seshasayee D et al (2012) Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol 130(1335\u20131343):e1335","journal-title":"J Allergy Clin Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02372-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02372-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02372-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:07:01Z","timestamp":1678968421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02372-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2372"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02372-w","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in line with the principles of the 1964 Declaration of Helsinki. Approval was granted by the National Health Research Institute and the Institutional Review Board of Taipei Veterans General Hospital, Taipei, Taiwan (approval number IRB:2019-01-007AC).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Studies involving human participants"}},{"value":"The Institutional Review Board of Taipei Veterans General Hospital, Taipei, Taiwan waived the need for written informed consent because the NHIRD dataset consisted of de-identified secondary data for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}